Clinical Trials on Breath Analysis in Korea, Democratic People's Republic of
Total 718 results
-
Novartis PharmaceuticalsCompletedAdvanced HER2-positive Breast Cancer or Gastric CancerTaiwan, Netherlands, Italy, United States, Belgium, United Kingdom, Korea, Republic of, France, Spain
-
Odonate Therapeutics, Inc.TerminatedBreast CancerUnited States, Korea, Republic of, Singapore
-
Kyoto Breast Cancer Research NetworkPfizerCompletedHormone Receptor Positive Malignant Neoplasm of Breast | Breast Cancer FemaleTaiwan, Japan, Korea, Republic of, Australia, Hong Kong
-
ASLAN PharmaceuticalsCompletedMetastatic Breast CancerAustralia, Hong Kong, Korea, Republic of, New Zealand, Philippines, Singapore, Taiwan
-
Samsung Medical CenterKorean Cancer Study Group; Health Insurance Review & Assessment ServiceUnknown
-
AstraZenecaDaiichi Sankyo, Inc.CompletedBreast CancerUnited States, Germany, Italy, Korea, Republic of, United Kingdom, Portugal, Australia, Japan, Canada, France
-
G1 Therapeutics, Inc.Active, not recruitingBreast Cancer | Breast Neoplasm | Carcinoma, Ductal, BreastUnited Kingdom, Bulgaria, Georgia, Moldova, Republic of
-
Gilead SciencesParexel; Iqvia Pty Ltd; Medidata SolutionsActive, not recruitingMetastatic Breast CancerKorea, Republic of, Taiwan, China
-
PfizerActive, not recruitingBreast CancerJapan, Korea, Republic of, Taiwan
-
Eli Lilly and CompanyCompletedBreast CancerChina, India, Turkey, Korea, Republic of, Brazil, Mexico
-
Taichung Veterans General HospitalRecruitingBreast Cancer | Lymphedema | Axillary Web Syndrome | Extracorporeal Shock Wave TherapyTaiwan
-
Hoffmann-La RocheCompletedSmall Cell Lung Carcinoma | Hepatocellular Carcinoma | Carcinoma, Non-Small Cell Lung | Urothelial Carcinoma | Triple Negative Breast CarcinomaKorea, Republic of
-
Farid MasoudCompletedAndrogenetic AlopeciaIran, Islamic Republic of
-
Novartis PharmaceuticalsCompletedAdvanced Triple Negative Breast Cancer (TNBC) With High TAMsFrance, Italy, Austria, Taiwan, United States, Spain, Australia, Korea, Republic of, Belgium, Germany, Hong Kong, Turkey
-
AryoGen Pharmed Co.Completed
-
Boehringer IngelheimCompletedBreast NeoplasmsUnited States, Australia, Hong Kong, Korea, Republic of, Thailand, Tunisia, United Kingdom
-
AryoGen Pharmed Co.CompletedMalignant Neoplasm of BreastIran, Islamic Republic of
-
National Cancer Center, JapanPfizer; Korean Cancer Study GroupActive, not recruitingBreast NeoplasmsKorea, Republic of, Singapore, Japan, Taiwan
-
Genentech, Inc.Active, not recruitingBreast CancerUnited States, Spain, Korea, Republic of, Australia, United Kingdom
-
Hoffmann-La RocheCompletedBreast CancerChina, Korea, Republic of, Taiwan, Thailand
-
Merck Sharp & Dohme LLCRecruitingBreast NeoplasmsIsrael, United States, Taiwan, Hong Kong, Korea, Republic of, Switzerland, Costa Rica
-
CinnagenCompletedHER2-positive Breast CancerIran, Islamic Republic of
-
SanofiCompletedBreast CancerUnited States, France, Canada, Germany, Italy, Netherlands, Spain, Switzerland, Turkey, Belgium, Argentina, Denmark, Colombia, Korea, Republic of, South Africa
-
PfizerRecruitingBreast Cancer | Head and Neck CancerKorea, Republic of, Mexico, Ukraine, United States
-
German Breast GroupPfizer; AGO Study Group; Breast International Group; NSABP Foundation IncCompletedBreast Cancer | Hormonreceptor Positive | Her2-normal | Postneoadjuvant Treatment With CDK 4/6 Inhibitor | CPS-EG ScoreUnited States, Australia, Austria, Canada, France, Germany, Ireland, Japan, Korea, Republic of, Spain, United Kingdom
-
AstraZenecaCompletedBreast CancerKorea, Republic of
-
Adherex Technologies, Inc.UnknownMetastatic Breast CancerUnited States, Russian Federation
-
Novartis PharmaceuticalsCompletedNeoplasms, BreastCanada, Netherlands, United States, Spain, Korea, Republic of
-
Hoffmann-La RocheTerminatedBreast CancerUnited States, Brazil, Australia, Canada, Japan, Korea, Republic of, Spain, United Kingdom
-
EMD SeronoTerminatedBreast CancerCzech Republic, Korea, Republic of, Russian Federation, South Africa, Germany, Slovakia, Austria, United States, Belgium, Poland, Israel, Australia
-
Odonate Therapeutics, Inc.TerminatedBreast CancerUnited States, Spain, Korea, Republic of, Taiwan, Australia, Canada
-
AstraZenecaRecruitingER+ HER2- Advanced Breast Cancer | High-grade Serous Ovarian Cancer (HGSOC)United States, United Kingdom, Korea, Republic of, Australia, Spain
-
Novartis PharmaceuticalsCompletedTriple-negative Breast CancerBelgium, Italy, Japan, Taiwan, United States, Australia, Singapore, Spain, Germany, Korea, Republic of, Argentina, Canada, France, Hungary, Israel, Lebanon, Thailand
-
Queen Mary University of LondonAstraZeneca; Cancer Research UKUnknownMetastatic Breast CancerKorea, Republic of, United Kingdom, Hungary, Georgia, France, Romania
-
Eli Lilly and CompanyActive, not recruitingPancreatic Cancer | Solid Tumor | Cutaneous Melanoma | Microsatellite Instability-High (MSI-H) Solid Tumors | Breast Cancer (HR+HER2-)Belgium, Spain, Korea, Republic of, United States, Taiwan, France, Canada
-
Stiefel, a GSK CompanyGlaxoSmithKlineCompletedAlopeciaKorea, Republic of, Taiwan, Singapore, Hong Kong, Chile
-
Puma Biotechnology, Inc.CompletedBreast Neoplasms | Advanced Breast Cancer | Advanced Malignant Solid TumorsUnited States, Belgium, China, Hong Kong, Canada, Korea, Republic of, India, Poland, Ukraine
-
Hoffmann-La RocheCompletedTriple-Negative Breast CancerUnited States, Korea, Republic of, Spain, Brazil, Taiwan, Germany, Russian Federation, Australia
-
AstraZenecaCompleted
-
Seoul National University HospitalNational Cancer Center, Korea; Chonbuk National University Hospital; Asan Medical... and other collaboratorsCompletedStage IV Lung Cancer | Stage IV Pancreatic Cancer | Stage IV Breast Cancer | Pediatric Brain Tumor | Stage IV Colon Cancer | Stage IV Gastric Cancer | Stage IV Liver Cancer | Malignant Hematologic Neoplasm | Pediatric Solid Tumor | Pediatric Lymphoma | Biliary Cancer Metastatic | Pediatric LeukemiaKorea, Republic of
-
Merck Sharp & Dohme LLCActive, not recruitingCarcinoma, Non-Small-Cell Lung | Solid Tumor | Pharmacokinetics | Triple Negative Breast NeoplasmsUnited States, Chile, Israel, Korea, Republic of, Netherlands, Spain, Taiwan
-
Synta Pharmaceuticals Corp.CompletedBreast Cancer | Triple Negative Breast Cancer | HER-2 Positive Breast Cancer | ER/Progressive Response (PR) + Refractory to Prior Hormonal TreatmentSpain, United States, Argentina, Belgium, Brazil, Korea, Republic of, Peru, United Kingdom
-
Novartis PharmaceuticalsCompletedColorectal Cancer, Non-small Cell Lung Carcinoma (Adenocarcinoma), Triple Negative Breast Cancer, Renal Cell CarcinomaUnited States, Spain, Taiwan, Germany, Netherlands, United Kingdom, Korea, Republic of
-
Hoffmann-La RocheRecruitingInoperable, Locally Advanced or Metastatic, ER-positive Breast CancerUnited States, Korea, Republic of, Spain, Australia, Israel
-
AstraZenecaDaiichi Sankyo Co., Ltd.; Daiichi Sankyo Company, LimitedActive, not recruitingMetastatic Breast CancerBelgium, United States, Taiwan, Korea, Republic of, Brazil, Russian Federation, Canada, Australia, France, Mexico
-
Novartis PharmaceuticalsActive, not recruitingBreast CancerUnited Kingdom, France, Australia, Korea, Republic of, Spain, Switzerland, Italy, United States
-
National Heart, Lung, and Blood Institute (NHLBI)CompletedHeart Defects, Congenital | Double Outlet Right Ventricle | Heart Septal Defects, Ventricle | Truncus Arteriosus, PersistentUnited States, Belarus, Ukraine
-
SanofiTerminatedBreast Cancer | Gastric Cancer | Neoplasm | Lung Neoplasm Malignant | Neoplasm MalignantBelgium, Korea, Republic of, United States, Taiwan, Spain, France
-
National Cancer Center, JapanRecruitingCervical Cancer | Nasopharyngeal Carcinoma | Ovarian Cancer | Triple Negative Breast Cancer | Endometrial Cancer | Ovarian Clear Cell CarcinomaJapan, Korea, Republic of, Malaysia, Thailand, Philippines, Singapore, Taiwan, Vietnam
-
OBI Pharma, IncCompletedMetastatic Breast CancerUnited States, Taiwan, Korea, Republic of, China, India